List of Publicly Traded Mid-Cap Medical Device and Equipment Companies Listed on U.S. Exchanges
A comprehensive directory of mid-cap medical device and equipment stocks with market capitalizations between $2 billion and $10 billion, featuring 2026 performance data, clinical pipeline highlights, and sector analysis.
This list includes mid-sized medical device, instrument, equipment and supply companies with market capitalizations between two billion and ten billion dollars. We update this page at the start of every month so it is possible that during the course of a month a company's market cap might fall below two billion or go above ten billion. The mid-cap medical device sector in 2026 is experiencing strong momentum, driven by neurovascular innovations, diabetes technology adoption, and AI-enabled diagnostics. Notable mid-cap leaders include Penumbra (PEN) in stroke treatment, DexCom (DXCM) in continuous glucose monitoring, and Repligen (RGEN) in bioprocessing technologies. Additional medical device companies can be found in the sections linked below.
Key Takeaways
Mid-cap medical device companies are at the forefront of innovation in neurovascular treatment, diabetes management, and minimally invasive surgery. Explore all medical device stocks across market caps for broader sector context and comparative analysis.
Leading mid-cap medtech stocks have outperformed in 2026, with Penumbra (PEN) up approximately 23% YTD on neurovascular strength and DexCom (DXCM) benefiting from expanding continuous glucose monitor adoption and favorable reimbursement trends.
Mid-cap device companies are frequent acquisition targets for larger strategics seeking innovative technologies. Recent deals in diagnostics and organ preservation technologies highlight continued consolidation in the $500B+ global medical device market.
Use the Mid-Cap Medical Device Industry Comparison Widget to analyze trends, earnings per share, P/E ratio, and beta across all companies on this list for informed decision-making.
Top Mid-Cap Medical Device and Equipment Stocks by Market Cap (2026)
A comparative overview of leading mid-cap medical device and equipment companies listed on major U.S. exchanges.
| Rank | Ticker | Company | Industry | Market Cap | YTD % | P/E Ratio | Div Yield |
|---|---|---|---|---|---|---|---|
| 1 | RMD | ResMed Inc. | Respiratory | $12.5B | +8.2% | 28.5 | 0.9% |
| 2 | COO | Cooper Companies | Eyes | $11.8B | +6.4% | 25.3 | N/A |
| 3 | WST | West Pharmaceutical Services | Drug Delivery | $10.5B | +11.3% | 35.2 | 0.3% |
| 4 | STE | Steris Corporation | Medical Devices | $9.8B | +5.7% | 32.8 | 0.8% |
| 5 | BIO | Bio-Rad Laboratories | Medical Devices | $9.2B | -2.1% | 28.9 | N/A |
| 6 | ALGN | Align Technology | Dental | $8.9B | +14.5% | 38.4 | N/A |
| 7 | DXCM | DexCom Inc. | Diabetes | $8.7B | +16.2% | 42.1 | N/A |
| 8 | TFX | Teleflex Incorporated | Medical Devices | $8.2B | +4.8% | 26.7 | 0.6% |
| 9 | BRKR | Bruker Corporation | Medical Devices | $7.5B | +9.2% | 30.5 | 0.2% |
| 10 | HAE | Haemonetics Corporation | Blood | $6.8B | +7.5% | 24.8 | N/A |
Mid-Cap Medical Device and Equipment Companies — Complete Company List
Additional medical device companies can be found in the following sections:
List of Medical Device Companies Large-Cap Medical Device Companies Small-Cap Medical Device Companies Micro-Cap Medical Device Companies Nano-Cap Medical Device CompaniesIn parentheses you will find a short description or areas of focus for the company. A comparison widget that shows trend, earnings per share (EPS), P/E ratio and beta for each of the companies on this list can be accessed through the link below.
Mid-Cap Medical Device Industry Comparison WidgetSelect the company's link to access charts, news links and company website and social media information.
Medical Devices: Mid-Cap Stocks
- Bio-Rad Laboratories, Inc. (BIO) (Life Science: laboratory instruments, apparatus, consumables and reagents; products for medical screening and diagnostics)
- Bruker Corporation (BRKR) (Analytical instruments including atomic force microscopy, magnetic technologies, spectroscopy, spectrometers, X-ray technologies)
- Hill-Rom Holdings Inc. (HRC) (Furniture, hospital beds, stretchers, support surfaces & mattresses, surgical products)
- ICU Medical, Inc. (ICUI) (Products used in critical care applications, oncology and vascular therapy)
- PerkinElmer, Inc. (PKI) (Electronic laboratory notebook and software, neonatal and newborn screening, cancer treatment, environmental)
- Steris Corporation (STE) (Healthcare: infection prevention and surgical products including sterilizers, surgical tables, consumable products, accessories; Life sciences: capital equipment, formulated cleaning chemistries)
- Teleflex Incorporated (TFX) (Single-use medical devices used in diagnostic and therapeutic procedures: anesthesia, cardiac care, EMS, interventional access, urology, vascular access)
- Varian Medical Systems, Inc. (VAR) (Oncology treatment systems and software, X-ray products)
Blood
- Haemonetics Corporation (HAE) (Blood management company: devices, services and software)
Dental
- Align Technology, Inc. (ALGN) (Dental equipment and devices)
Diabetes
- DexCom, Inc. (DXCM) (Glucose monitoring systems)
- Insulet Corporation (PODD) (Tubeless insulin pump; distributor of diabetes products and supplies)
Drug Delivery
- West Pharmaceutical Services, Inc. (WST) (Drug delivery systems, components, pre-fillable solutions)
Eyes
- Cooper Companies, Inc. (The) (COO) (Soft contact lens, medical devices and procedure-based products used in the women's healthcare market)
Heart
- Abiomed Inc. (ABMD) (Heart support and recovery products and services; heart pumps, artificial heart)
- LivaNova plc (LIVN) (Medical technology and service company; operates in three business units: Cardiac Rhythm Management, Cardiac Surgery and Neuromodulation)
Kidney
- Cantel Medical Corp. (CMD) (Water purification equipment and services; health care disposables, endoscopy procedure disposables, medical device reprocessing systems for endoscopy and renal dialysis)
Monitoring Equipment
- Masimo Corporation (MASI) (Monitoring technologies)
Orthopedics
- Integra LifeSciences Holdings Corporation (IART) (Regenerative technology implants, medical devices; areas of focus include orthopedic, spine and general surgery)
- Wright Medical Group N.V. (WMGI) (Medical devices for orthopedics: upper extremity, lower extremity and biologics markets)
Respiratory
- ResMed Inc. (RMD) (Sleep and respiratory medicine equipment)
Spine and Musculoskeletal
- Globus Medical, Inc. (GMED) (Musculoskeletal implant manufacturer)
- Nevro Corp. (NVRO) (Spinal cord stimulation system used in the treatment of chronic pain)
- NuVasive, Inc. (NUVA) (Minimally disruptive surgical products for the spine)
Strokes
- Penumbra, Inc. (PFN) (IPO in September 2015: Medical devices for strokes and peripheral vascular conditions)
Risks & Considerations
Regulatory and Reimbursement Risk
Medical device companies face stringent FDA approval processes and evolving reimbursement policies from Medicare and private insurers. Delays in product approvals or unfavorable coverage determinations can materially impact revenue projections for mid-cap device makers.
Clinical Trial and Product Liability
New device technologies require extensive clinical validation. Trial failures, safety concerns, or product recalls can trigger significant stock price declines and expose companies to litigation risk, particularly for novel neurovascular and implantable device technologies.
Competitive and Technological Obsolescence
The medtech industry is characterized by rapid innovation cycles. Mid-cap companies must continuously invest in R&D to maintain competitive positioning against both larger incumbents and emerging startups with disruptive technologies.
Hospital Capital Spending Cycles
Many mid-cap device companies rely on hospital capital equipment purchases, which are sensitive to healthcare system budgets and economic conditions. Deferred spending during periods of margin pressure can create revenue lumpiness and earnings volatility.